Mexico Digestive Remedies Market Report: Trends, Growth and Forecast (2026-2032)
By Product Type (Paediatric Digestive Remedies (Paediatric Diarrhoeal Remedies, Paediatric Indigestion & Heartburn Remedies, Paediatric Laxatives, Paediatric Motion Sickness Remedies), Diarrhoeal Remedies, IBS Treatments, Indigestion & Heartburn Remedies (Antacids, Antiflatulents, Digestive Enzymes, H2 Blockers, Proton Pump Inhibitors), Laxatives, Motion Sickness Remedies), By Age Group (Children & Adolescents (01-17 years), Adults (18-65 years), Geriatric (65+ years)), By Sales Channel (Retail Online, Retail Offline (Hospitals, Clinics, Pharmacies))
|
Major Players
|
Mexico Digestive Remedies Market Statistics and Insights, 2026
- Market Size Statistics
- Digestive remedies market size in Mexico was valued at USD 895 million in 2025 and is estimated at USD 919 Million in 2026.
- The market size is expected to grow to USD 1.08 billion by 2032.
- Market to register a CAGR of around 2.72% during 2026-32.
- Product Type Shares
- Diarrhoeal remedies grabbed market share of 35%.
- Competition
- More than 20 companies are actively engaged in producing digestive remedies in Mexico.
- Top 5 companies acquired around 30% of the market share.
- Eurofarma Laboratorios SA, Procter & Gamble de Mexico SA de CV, GlaxoSmithKline Mexico SA de CV, Genomma Lab Internacional SAB de CV, Sanofi-Aventis de Mexico SA de CV etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 90% of the market.
Mexico Digestive Remedies Market Outlook
The Mexico digestive remedies market size was valued at USD 895 million in 2025 and is projected to grow from USD 919 million in 2026 to USD 1.08 billion by 2032, exhibiting a CAGR of around 2.72% during the forecast period. Growth is supported by the steady need for fast relief from everyday digestive discomfort. Diets rich in spicy, fatty, and processed foods keep heartburn, reflux, and stomach unease common, encouraging consumers to rely on quick over-the-counter solutions for symptom control.
Demand for digestive remedies is also linked with broader health awareness and nutrition initiatives. In 2025, Mexican Social Security Institute (IMSS) reports 717 nutrition professionals in first-level care, 2,523 operational staff in second level, and 1,857 in third level working on nutrition guidance and prevention. Within product segments, diarrhoeal remedies constitute approximately 35% of the category, reflecting strong demand for rapid‑response treatments that address sudden gastric issues across all age groups.
At the same time, the category is facing the pressure due to the changing consumer behaviour. The purchasing patterns are being transformed by economic prudence and the increasing popularity of preventative gut-health solutions. The Ministry of Health states that the gastrointestinal tract contains more than 400 bacterial species, highlighting the scientific role of probiotics in intestinal health and immune function. This increases consumer interest in microbiota-focused solutions, which can draw attention away from traditional digestive remedies used mainly for immediate symptom relief.
Distribution remains strongly anchored in traditional channels. Retail offline accounts for about 90% of sales, as pharmacies continue to be the most trusted and accessible place for immediate purchases. According to National Institute of Statistics and Geography (INEGI), annual inflation reaches 4.02% in February 2026, keeping price comparison and value-for-money important in everyday buying decisions. In this environment, physical retail supports digestive remedies sales by allowing consumers to compare brands and buy quickly when symptoms appear.

Mexico Digestive Remedies Market Growth DriverFast Relief Stays Essential in Daily Life
An essential factor behind the demand for Mexican digestive remedies products is the ongoing demand for fast relief to everyday complaints such as an upset stomach from eating too much spicy, fatty and/or processed food all contribute to the continued relevance of heartburn, reflux and nausea and therefore the ongoing reliance by consumers upon antacid products. Therefore, the usage of these types of products remain associated with the daily activities of consumers due to their preference for effective immediate relief as opposed to delaying treatment until after experiencing a symptom.
This need is also present in a larger health-conscious environment. The Mexican Social Security Institute (IMSS) has indicated that in 2025, it has 717 nutrition professionals in first-level care, 2,523 in second-level services, and 1,857 in third-level services, all of which are dedicated to nutrition guidance, prevention, and healthier habits. This institutional focus on nutrition and digestive health maintains the presence of stomach-related care and supports the minimum demand of digestive remedies.
Mexico Digestive Remedies Market ChallengeBudget Caution Slows Premium OTC Momentum
One of the main issues facing the Mexico digestive remedies market is the combination of financial constraint and the move to non-traditional digestive care. As consumers still report digestive discomfort, a number of consumers are operating on tight budgets and becoming more selective in their over-the-counter buying. This slows down category momentum, especially among traditional synthetic remedies which are under pressure not only against cheaper substitutes but also more preventive, wellness-oriented ones.
At the same time, natural and microbiota-based products are becoming legitimate. In 2025, the Ministry of Health in Mexico reported that the gastrointestinal tract contains over 400 species of bacteria and confirmed that the best clinical evidence of probiotics is associated with intestinal health and immune stimulation. This boosts consumer trust in probiotics, herbal supplements, and preventive gut-health products, which can shift demand off the conventional over-the-counter digestive products.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Mexico Digestive Remedies Market TrendGut Microbiota Care Moves Into the Mainstream
A major trend in the Mexico digestive remedies market is that probiotics and prebiotics are becoming more integral to the market. There is increasing consumer awareness of the importance of microbiota balance in the digestive system, and this is driving the market to become more preventive and evidence-based. As a result, the market for digestive care is becoming more associated with overall wellness, daily care, and long-term stomach comfort.
This is being fueled by public health information. In 2025, the Ministry of Health informs that “the gastrointestinal tract harbors more than 400 bacterial species and that probiotics have been strongly associated with intestinal health and immune function.” They also report that “proper nutrition and healthy lifestyle habits can help to ensure nutrient absorption and regular intestinal transit.”
Mexico Digestive Remedies Market OpportunityOlder Consumers Create Room for Targeted Relief
Another opportunity that is unique in the Mexico digestive remedies market is more specific solutions to older adults, who tend to have more frequent digestive discomfort and need frequent relief. The category can be expanded with products placed around easier digestion, reflux control, constipation relief, and daily stomach balance, especially when these solutions seem practical, reliable, and simple to use.
This opportunity is supported by Mexico’s demographic shift. In 2025, an official National Institute for Older Adults (INAPAM) publication citing National Population Council (CONAPO) estimates states that Mexico has 17,121,580 older adults, representing 12.8% of the total population. As this group grows, the need for digestive support becomes more relevant across multiple subcategories. At the same time, the federal health sector’s 2024–2030 programme places stronger emphasis on prevention and health promotion, which supports better alignment between digestive care and healthy ageing.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Mexico Digestive Remedies Market Segmentation Analysis
By Product Type
- Paediatric Digestive Remedies
- Paediatric Diarrhoeal Remedies
- Paediatric Indigestion & Heartburn Remedies
- Paediatric Laxatives
- Paediatric Motion Sickness Remedies
- Diarrhoeal Remedies
- IBS Treatments
- Indigestion & Heartburn Remedies
- Antacids
- Antiflatulents
- Digestive Enzymes
- H2 Blockers
- Proton Pump Inhibitors
- Laxatives
- Motion Sickness Remedies
The segment has the highest share around segment under the product type, where diarrhoeal remedies grabbed market share of 35%. This leading position reflects the category’s broad everyday relevance. Diarrhoeal remedies are used across age groups and are often linked with immediate consumer need, which gives them a strong place in household purchasing. Their role is further supported by rising awareness of oral rehydration and the wider use of complementary hydration products.
The segment also benefits from the fact that consumers often prioritise practical and familiar solutions when symptoms appear suddenly. In a market where affordability and accessibility remain important, diarrhoeal remedies fit well with quick-response health behaviour and repeat use. That helps the segment maintain a strong market position even while probiotics, preventive products, and other digestive formats continue to gain more attention.

By Sales Channel
- Retail Online
- Retail Offline
- Hospitals
- Clinics
- Pharmacies
The segment has the highest share around segment under the sales channel, where retail offline grabbed 90% of the market. This strong lead fits the Mexican market because digestive remedies are often bought in response to immediate discomfort, and physical pharmacies remain the most trusted and accessible point of purchase. Consumers value being able to compare formats, check prices directly, and seek quick guidance from pharmacy staff before choosing a remedy.
Offline strength also matches wider consumer behaviour in a still price-conscious market. In February 2026, INEGI reports annual inflation of 4.02%, which keeps value-for-money decisions central in everyday shopping. In that environment, physical retail remains important because it allows consumers to compare branded and generic products easily and make fast symptom-led purchases. That keeps retail offline clearly ahead of digital channels in digestive remedies.
List of Companies Covered in Mexico Digestive Remedies Market
The companies listed below are highly influential in the Mexico digestive remedies market, with a significant market share and a strong impact on industry developments.
- Eurofarma Laboratorios SA
- Procter & Gamble de Mexico SA de CV
- GlaxoSmithKline Mexico SA de CV
- Genomma Lab Internacional SAB de CV
- Sanofi-Aventis de Mexico SA de CV
- Takeda Mexico SA de CV
- Reckitt Benckiser Mexico SA de CV
- Pisa Laboratorios SA
- Janssen-Cilag SA de CV
- Abbott Laboratorios de Mexico SA de CV
Competitive Landscape
In 2025, the competitive landscape of digestive remedies in Mexico was led by Genomma Lab Internacional SAB de CV with an 11.2% retail value share, followed by Sanofi-Aventis de Mexico SA de CV at 8%. Genomma Lab maintains its leadership through a strong portfolio of well-known products such as Genoprazol and Estomacurol, which target common digestive problems including heartburn, acid reflux and stomach discomfort. The company also benefits from strong brand visibility supported by extensive marketing across television and social media, as well as a consumer-focused strategy that adapts product formats and flavours to local preferences. Sanofi-Aventis holds a notable position through its established gastrointestinal treatment portfolio and strong distribution presence. Demand for digestive remedies in Mexico continues to be supported by the high prevalence of digestive conditions such as heartburn and gastroesophageal reflux disease, largely linked to diets rich in spicy, fatty and processed foods. However, growth in 2025 has slowed compared to previous years due to economic uncertainty and increasing consumer price sensitivity. At the same time, the category is facing rising competition from natural alternatives such as probiotics, herbal teas and dietary supplements, as many consumers increasingly favour preventive and holistic approaches to digestive health. Pharmacies remain the dominant distribution channel due to their wide availability, trusted pharmacist advice and broad range of digestive health products across different price points.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Mexico Digestive Remedies Market Policies, Regulations, and Standards
- Mexico Digestive Remedies Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Mexico Digestive Remedies Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product Type
- Paediatric Digestive Remedies- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Diarrhoeal Remedies- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Indigestion & Heartburn Remedies- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Laxatives- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Motion Sickness Remedies- Market Insights and Forecast 2022-2032, USD Million
- Diarrhoeal Remedies- Market Insights and Forecast 2022-2032, USD Million
- IBS Treatments- Market Insights and Forecast 2022-2032, USD Million
- Indigestion & Heartburn Remedies- Market Insights and Forecast 2022-2032, USD Million
- Antacids- Market Insights and Forecast 2022-2032, USD Million
- Antiflatulents- Market Insights and Forecast 2022-2032, USD Million
- Digestive Enzymes- Market Insights and Forecast 2022-2032, USD Million
- H2 Blockers- Market Insights and Forecast 2022-2032, USD Million
- Proton Pump Inhibitors- Market Insights and Forecast 2022-2032, USD Million
- Laxatives- Market Insights and Forecast 2022-2032, USD Million
- Motion Sickness Remedies- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Digestive Remedies- Market Insights and Forecast 2022-2032, USD Million
- By Age Group
- Children & Adolescents (01-17 years)- Market Insights and Forecast 2022-2032, USD Million
- Adults (18-65 years)- Market Insights and Forecast 2022-2032, USD Million
- Geriatric (65+ years)- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics- Market Insights and Forecast 2022-2032, USD Million
- Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product Type
- Market Size & Growth Outlook
- Mexico Paediatric Digestive Remedies Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Age Group- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Mexico Diarrhoeal Remedies Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Age Group- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Mexico IBS Treatments Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Age Group- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Mexico Indigestion & Heartburn Remedies Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Age Group- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Mexico Laxatives Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Age Group- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Mexico Motion Sickness Remedies Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Age Group- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- Genomma Lab Internacional SAB de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Sanofi-Aventis de Mexico SA de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Takeda Mexico SA de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Reckitt Benckiser Mexico SA de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Pisa Laboratorios SA
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Eurofarma Laboratorios SA
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Procter & Gamble de Mexico SA de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- GlaxoSmithKline Mexico SA de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Janssen-Cilag SA de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Abbott Laboratorios de Mexico SA de CV
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Genomma Lab Internacional SAB de CV
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product Type |
|
| By Age Group |
|
| By Sales Channel |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











